Programmed cell death and natural killer cells in multiple sclerosis: new potential therapeutic targets?

被引:3
|
作者
Beatrice Macchi
Antonio Mastino
机构
[1] Department of Systems Medicine, University of Rome "Tor Vergata"
[2] Department of Chemical, Biological, Pharmaceutical, and Environmental Sciences, University of Messina
[3] The Institute of Translational Pharmacology,CNR
关键词
new potential therapeutic targets; cell; MS;
D O I
暂无
中图分类号
R744.51 [];
学科分类号
1002 ;
摘要
Multiple sclerosis(MS)is a chronic,severe and complex disease of still uncertain etiopathogenesis,with lesions in the cerebral white matter and spinal cord.The disease is heterogeneous,but is characterized by neuroinflammatory and neurodegenerative processes,usually associated with altered activation of the immune system following presumable stimulation by still unknown autoantigens.Several data confirm that
引用
收藏
页码:733 / 734
页数:2
相关论文
共 50 条
  • [31] The therapeutic potential of natural killer cells to target medulloblastoma
    Perez-Martinez, Antonio
    Fernandez, Lucia
    Angel Diaz, Miguel
    EXPERT REVIEW OF ANTICANCER THERAPY, 2016, 16 (06) : 573 - 576
  • [32] Therapeutic potential of natural killer cells in neuroimmunological diseases
    Zhang, Qing
    Lin, Jing
    Yang, Mengge
    Li, Zhijun
    Zhang, Min
    Bu, Bitao
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 173
  • [33] The therapeutic potential of natural killer cells in neuropathic pain
    Kim, Hyoung Woo
    Wang, Shuaiwei
    Davies, Alexander J.
    Oh, Seog Bae
    TRENDS IN NEUROSCIENCES, 2023, 46 (08) : 617 - 627
  • [34] Potential therapeutic role of natural killer cells in cancer
    Woan, Karrune
    Reddy, Vijay
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2007, 7 (01) : 17 - 29
  • [35] Therapeutic Potential of Natural Killer Cells in Gastric Cancer
    Du, Yu
    Wei, Yongchang
    FRONTIERS IN IMMUNOLOGY, 2019, 9
  • [36] Selected Interleukins Relevant to Multiple Sclerosis: New Directions, Potential Targets and Therapeutic Perspectives
    Mado, Hubert
    Stasiniewicz, Artur
    Adamczyk-Sowa, Monika
    Sowa, Pawel
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (20)
  • [37] Immunosenescence in multiple sclerosis: the identification of new therapeutic targets
    Dema, Maria
    Eixarch, Herena
    Villar, Luisa M.
    Montalban, Xavier
    Espejo, Carmen
    AUTOIMMUNITY REVIEWS, 2021, 20 (09)
  • [38] THERAPEUTIC TARGETS FOR MULTIPLE SCLEROSIS
    Sorbera, L. A.
    Dulsat, C.
    Rosa, E.
    DRUGS OF THE FUTURE, 2009, 34 (05) : 405 - 417
  • [39] Natural products: Potential therapeutic agents in multiple sclerosis
    Yu, Shuangwen
    Liu, Mei
    Hu, Kaili
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2019, 67 : 87 - 97
  • [40] Natural killer T cells as targets for therapeutic intervention in autoimmune diseases
    Wilson, MT
    Van Kaer, L
    CURRENT PHARMACEUTICAL DESIGN, 2003, 9 (03) : 201 - 220